"We Envision Growth Strategies Most Suited
to Your Business"
The U.S. home infusion therapy market size is anticipated to display robust growth by attaining USD 33.20 billion by 2030. Fortune Business Insights™ in its report titled “U.S. Home Infusion Therapy Market Size, Share & COVID-19 Impact Analysis, By Product (Devices, Drugs, and Services), By Indication (Enteral Nutrition, Anti-Infective, Chemotherapy, Hydration Therapy, Total Parenteral Nutrition, Immunoglobulins, and Others) and Forecast, 2023-2030” observes that the market size in 2022 stood at USD 17.26 billion and reached USD 18.82 billion in 2023. The market is projected to record a strong CAGR of 8.4% during 2023-2030. Growing incidences of chronic diseases, rising geriatric population, and high cost of hospital stays are the factors driving market expansion. Furthermore, a rise in the number of home infusion therapy options and infusion drugs available to patients will aid market proliferation in the upcoming years.
Collaboration Between Bio Compression Systems and InfuSystem Holdings Inc. to Provide Lymphedema Therapy to Elevate Market Proliferation
InfuSystem Holdings, Inc., a leading healthcare services provider, announced its decision to enter a joint agreement with Bio Compression Systems, Inc. Under this agreement, InfuSystem will also provide Lymphedema Therapy on its Integrated Therapy Service platform. InfuSystem’s turnkey solutions will also include providing pneumatic compression devices with non-calibrated and calibrated gradient pressure, garments, and certified technicians for proper fitting of the compression system.
Increasing Popularity of Home Infusion Therapy to Propel Market Proliferation Amid the Pandemic
The COVID-19 outbreak across the world resulted in the implantation of stringent lockdowns and social distancing norms in several economies. People were forced to stay at home to curb the rising number of cases which in turn elevated the number of people receiving home infusion therapy and aided market expansion. Moreover, infusion pumps were increasingly used to treat COIVID-19 patients especially after the emergency use authorization of these pumps for monoclonal antibody treatments by the FDA which contributed to market growth in the pandemic.
Economic and Clinical Benefits of Home Infusion Therapies to Drive Market Augmentation
Healthcare agencies and the government are making efforts to promote home infusion therapy and encourage its adoption among patients due to the growing economic burden of treatments in healthcare facilities and hospitals. Moreover, a shortage of physicians, beds and other resources has increased the number of patients preferring treatment in homecare settings which is driving U.S. home infusion therapy market growth. Furthermore, home therapies are more economical as they eliminate additional costs such as hospital inpatient stays, hospital visits, and examination charges which propel their adoption among patients.
On the other hand, concerns regarding the safety of home infusion therapies among patients and healthcare professionals is a key factor hindering market proliferation. Additionally, the absence of a physician in case of an adverse event or emergency will pose as a challenge hampering market growth.
To get a detailed report summary and research scope of this market, click here:
Growing Focus on Research and Development Activities to Launch Advanced Products to Aid Market Proliferation
Industry leaders in the market often take tactical or strategic decisions to improve profit margins, generate higher revenues, and enhance geographical reach. These decisions include partnerships, collaborations, mergers & acquisitions and product launches. In some cases, they participate in research and development activities and launch advanced products to meet rising demand from consumers. For example, in January 2021, OSU alumnus unveiled a new technology, IV Ensure, which is aimed at revolutionizing at-home infusion treatment. The device uses remote monitoring to help patients monitor their health and enhance compliance thus improving health outcomes.
Notable Industry Development
List of Key Companies Profiled in the Report:
Further Report Findings
Table of Segmentation
CAGR of 8.4% from 2023 to 2030
Value (USD billion)
By Product, Indication